Reperfusion failure: a study using electrocardiographic criteria
Background: The incidence of ischemic heart disease and myocardial infarction is increasing in developing nations. One measure that consistently improves outcomes in patients with myocardial infarction is early reperfusion. In resource-constrained settings, reperfusion is often achieved with thrombolysis rather than percutaneous coronary intervention. Our study aimed to determine, by using electrocardiographic criteria, the failure rate of reperfusion with thrombolysis by streptokinase in patients presenting to a tertiary hospital in south India. We also aimed to find the factors associated with failure of thrombolysis in the population under study.
Methods: Patients diagnosed to have acute myocardial infarction and thrombolysed with streptokinase were taken for the study. Failure of thrombolysis was defined by electrocardiographic criteria as less than 50% resolution in ST segment elevation in the worst affected lead after thrombolysis.
Results: Reperfusion with streptokinase had a high rate of failure. Diabetes smoking longer symptom needle time and higher admission rates and blood pressure and heart rates were factors associated with failure.Conclusion: Thrombolysis with streptokinase has a high rate of failure and certain specific factors are associated with reperfusion failure.
Robert WY, Stephen S, Malini C, Michael S, Joseph VS, Alan S. Population trends in the incidence and outcome of acute myocardial infarction. N Engl J Med. 2010;362:2155-65.
Reddy K, Yusuf S. Emerging epidemic of cardiovascular disease in developing countries. Circulat. 1998;97:596-601.
Malhotra S, Gupta M, Chandra KK, Grover A, Pandhi P. Prehospital delay in patients hospitalized with acute myocardial infarction in the emergency unit of a North Indian tertiary care hospital. Indian Heart J. 2003;55:349-53.
Hiremath JS. Future of thrombolytic therapy: an Indian context. J Assoc Physicians India. 2011;59:49-50.
William JR, John AM, William PH, William AB, Patrick LW, Russel CR. Prospective randomized trial of intracoronary vs. intravenous streptokinase in acute myocardial infarction. Circulat. 1983;68:1051-61.
Fibrinolytic Therapy Trialists' (FTT) Collaborative. Indications for finbrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mort. Lancet. 1994;343:311-22.
The GUSTO Angiographic Investigators. The effects of tissue plasminogen activator, streptokinase or both on coronary-artery patency, ventricular function and survival after acute myocardial infarction. N Engl J Med. 1993;329(22):1615-22.
Califf RM, White HD, Van de Werf F, Sadowski Z, Armstrong PW, Vahanian A, Simoons ML, Simes RJ, Lee KL, Topol EJ. One year results from the global utilization of streptokinase and TPA for occluded coronary arteries (GUSTO-I) trial. Circulat. 1996;94:1233-8.
Sikri N BA. A History of streptokinase use in acute myocardial infarction. Tex heart Inst J. 2007;34:318-27.
Vaishnav A, Vaishnav A, Khandekar S, Vaishnav S. Pre-hospital thrombolysis. J Assoc Physicians India. 2011;59 (Suppl):14-8.
Sutton AG, Campbell PG, Price DJ. Failure of thrombolysis by streptokinase: detection with a simple electrocardiographic method. Heart. 2000;84:149-56.
Schroder R, Wegscheider K, Schröder K, Dissmann R, Meyer-Sabellek W. Extent of early ST segment elevation resolution: a strong predictor of outcome in patients with acute myocardial infarction and a sensitive measure to compare thrombolytic regimens. J Am Coll Cardiol. 1995;26:1657-64.
Serruys PW, Simoons ML, Suryapranata H, Vermeer F, Wijns W, van den Brand M, Bär F, Zwaan C, Krauss XH, Remme WJ et al. Preservation of global and regional left ventricular function after early thrombolysis in acute myocardial infarction. J Am Coll Cardiol. 1986;7:729-42.
Barbagelata A, Perna ER, Clemmensen P, Uretsky BF, Canella JP, Califf RM. Time to reperfusion in acute myocardial infarction. It is time to reduce it! J Electrocardiol. 2007;40:257-64.
Stranders I, Diamant M, van Gelder RE, Spruijt HJ, Twisk JW, Heine RJ, Visser FC. Admission blood glucose level as risk indicator of death after myocardial infarction in patients with and without diabetes mellitus. Arch Int med. 2004;164:982-8.
Vujosevic S, Radojevic N, Belada N. Influence of admission glucose profile and hemoglobin A1c on complications of acute myocardial infarction in diabetic patients. Eur Rev Med Pharmacol Sci. 2013;17(9):1252-7.
Richards AM, Nicholl MG, Troughton RW. Antecedent hypertension and heart failure after myocardial infarction. J Am Coll cardiol. 2002;39:1182-8.
Rakugi H, Yu H, Kamitani A, Nakamura Y, Ohishi M, Kamide K, Nakata Y, Takami S, Higaki J, Ogihara T. Links between hypertension and myocardial infarction. Am Heart J. 1996;132(1 Pt 2 Su):213-21.
Bangalore S, Messerli FH, Ou FS, Tamis-Holland J, Palazzo ARoe MT. The association of admission heart rate and in hospital cardiovascular events in patients with non - ST segment elevation acute coronary syndromes: results from 135164 patinets in the CRUSADE quality improvement initiative. Eur Heart J. 2010;31:552-60.
Han Z, Yan-min Y, Jun Z, Li-sheng L, Hui-qiong T, Yao L. Prognostic value of admission heart rate in patients with ST-segment elevation myocardial infarction: role of type 2 diabetes mellitus. BMC Cardiovasc Dis. 2012;12:104.
Barbash GI, White HD, Modan M, Diaz R, Hampton JR, Heikkila J. Significance of smoking in patiebts receiving thrombolytic therapy for acute myocardial infarction. Experience gleaned from the international tissue plasminogen activator / streptokinase mortality trial. Circulat. 1993;87:53-8.
Andrikopoulos GK, Richter DJ, Dilaveris PE, Pipilis A, Zaharoulis A, Gialafos JE. In hospital mortality of habitual cigarette smokers after acute myocardial infarction and the smokers paradox in a countrywide study. Eur Heart J. 2001;22:776-84.